PDS Biotechnology Corporation (PDSB) Statistics & Valuation Metrics - Stocknear

PDS Biotechnology Corpora...

NASDAQ: PDSB · Real-Time Price · USD
1.20
-0.02 (-1.64%)
At close: Sep 05, 2025, 3:59 PM
1.22
1.67%
After-hours: Sep 05, 2025, 07:05 PM EDT

PDS Biotechnology Statistics

Share Statistics

PDS Biotechnology has 46.63M shares outstanding. The number of shares has increased by 24.15% in one year.

46.63M
24.15%
2.51%
20.3%
44.87M
2,899
0.57%

Short Selling Information

The latest short interest is 1.92M, so 4.11% of the outstanding shares have been sold short.

1.92M
4.11%
4.24%
5.4

Valuation Ratios

The PE ratio is -1.58 and the forward PE ratio is -1.67. PDS Biotechnology's PEG ratio is 0.06.

-1.58
-1.67
0
5
3.13
-1.69
0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for PDS Biotechnology.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.64, with a Debt / Equity ratio of 1.15.

2.64
2.64
1.15
-0.65
-0.62
-7.77

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.57M
24
0
n/a

Taxes

-869K
2.26%

Stock Price Statistics

The stock price has increased by -59.04% in the last 52 weeks. The beta is 1.15, so PDS Biotechnology's price volatility has been higher than the market average.

1.15
-59.04%
1.21
1.44
47.89
512,756

Income Statement

n/a
-59.79K
-36.32M
-37.61M
-33.75M
-33.81M
-1.03
Full Income Statement

Balance Sheet

The company has 41.69M in cash and 21.83M in debt, giving a net cash position of 19.86M.

41.69M
21.83M
19.86M
-182.11M
40.48M
31.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -35.03M and capital expenditures -29K, giving a free cash flow of -35.06M.

-35.03M
-29K
-35.06M
-0.96
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

PDSB does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for PDSB is $10, which is 733.3% higher than the current price. The consensus rating is "Buy".

$10
733.3%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Mar 18, 2019. It was a backward split with a ratio of 1:20.

Mar 18, 2019
backward
1:20

Scores

-7.34
3